Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05706636

T Central Memory Cells in Early Localized Non-Segmental Vitiligo

Conditions: Vitiligo

Sex: All
Ages: 12 Years – 60 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 30
Sponsor: Cairo University

Location: Egypt

Summary

Assessing the level of circulating TCMs (cluster of differentiation (CD) 8+, CD3+,C- chemokine receptor (CCR)7, cluster of differentiation 45 receptor (CD45R) cells) in early localized vitiligo cases prior to treatment and after treatment in comparison to healthy controls. This, in turn, would provide insights regarding the role of TCMs in vitiligo and the role of early treatment in halting disease progression and autoimmune memory formation that accounts for high recurrence rate of vitiligo

Eligibility Criteria

Inclusion Criteria:- Subjects with vitiligo localized to one anatomical area, of ≤ 6 months' durationExclusion Criteria:Patients who received treatment of any type (topical or systemic) within the last 3 months

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05706636). StuddyBuddy aggregates publicly available trial information.